Quarterly report pursuant to Section 13 or 15(d)

Stock Incentive Plan (Details Narrative)

v3.23.1
Stock Incentive Plan (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Oct. 31, 2017
Apr. 30, 2016
Stock Option Grants Term Period 10 years      
Aggregate intrinsic value of outstanding vested stock options $ 500,000      
Weighted-average exercise price $ 4.01      
Unamortized unvested balance of stock base compensation $ 410,000      
Unamortized unvested balance of stock base compensation, period 3 years      
Weighted Average Stock Options Expected To Vest $ 3.45      
Description of exercise price exercise prices ranging from $2.37 to $3.16 per share which vest over 1 to 4 years. All stock option grants have a 10-year term.      
Weighted average vested exercise price $ 4.42      
Stock Option Granted 508,902      
Stock-based compensation expense (non-cash) $ 476,209 $ 499,812    
Minimum Member        
Risk free interest rate 3.50%      
Expected term 5 years 3 months 18 days      
Volatility 90.00%      
Maximum Member        
Risk free interest rate 4.00%      
Expected term 6 years 1 month 6 days      
Stock award pool [Member]        
Share based compensation arrangement by share based payment award number of additional shares authorized 1,500,000      
2016 Stock Incentive Plan        
Share based compensation arrangement by share based payment award number of shares authorized       700,000
October 2017 | Board of Directors        
Share based compensation arrangement by share based payment award number of shares authorized     1,600,000  
April 2020 | Board of Directors        
Share based compensation arrangement by share based payment award number of shares authorized 3,100,000      
Vested 6/48ths on 6 month anniversary of grant date and 1/48th per month thereafter        
Option to purchase shares 443,182      
Vested quarterly over one year        
Option to purchase shares 55,720      
Vested monthly over one year        
Option to purchase shares 10,000      
Options [Member]        
Aggregate Stock Option Purchase Of Shares 508,902      
Research and Development Expenses        
Stock-based compensation expense (non-cash) $ 231,872 295,338    
Research and Development Expense [Member]        
Stock-based compensation expense (non-cash) $ 244,337 $ 204,474